Pfizer
BESPONSA
Manufacturer:
Pfizer
Name:
BESPONSA
HCPCS Code Descriptor:
Injection, inotuzumab ozogamicin, 0.1 mg
Category:
J Code
HCPCS:
J9229
NDC(s):
00008-0100-01
Primary Type:
Oncology
Generic Status:
Single-Source
Route of Administration:
Intravenous
About:
BESPONSA is an Oncology drug manufactured by Pfizer and administered via the Intravenous route of administration. The J Code: J9229 is aligned to the drug BESPONSA.
Access Pricing and More By Registering
HCPCS Added Date:
1/1/19
HCPCS Effective Date:
1/1/19
HCPCS Short Description:
Inj inotuzumab ozogam 0.1 mg
Billing and Coding Guide:
https://www.pfizeroncologytogether.com/files/Besponsa_Sample_CMS-1500_Form_(Physician's_Office).pdf
Patient Assistance:
https://www.pfizerrxpathways.com/
https://www.pfizeroncologytogether.com/